Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited (BXPHF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bxphf · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Botanix Pharmaceuticals LimitedYou BXPHF | $51M | N/A | — | — |
 Ascend Wellness Holdings, Inc. AAWH | $114M | N/A | — | -$0.58 |
 Brii Biosciences Limited BRIBF | $167M | N/A | — | -$0.30 |
 Hofseth BioCare ASA HOFBF | $66M | N/A | — | -$0.33 |
 Innate Pharma S.A. IPHYF | $211M | N/A | — | -$0.55 |
 JW (Cayman) Therapeutics Co. Ltd JWCTF | $148M | N/A | — | -$1.30 |
 Kintor Pharmaceutical Limited KNTPF | $265M | N/A | — | -$0.43 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Botanix Pharmaceuticals Limited (BXPHF) measures how much investors pay for each dollar of the company's trailing earnings. BXPHF's current PE ratio of N/A is calculated by dividing its stock price of $0.03 by its TTM earnings per share of —.
Frequently asked questions
BXPHF pe ratio · 6 questionsBXPHF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.03 and TTM EPS of —. Data sourced from Financial Modeling Prep via BXPHF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Botanix Pharmaceuticals Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09